Literature DB >> 1805353

Reduced neuronal size in posterior hippocampus of schizophrenic patients.

F M Benes1, I Sorensen, E D Bird.   

Abstract

The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This article has employed quantitative morphometric techniques to determine whether abnormalities of posterior hippocampal cross-sectional area, as well as the number, size, and degree of disarray of pyramidal neurons were present in 9 control and 14 schizophrenic subjects. Seven schizophrenic patients showed evidence of superimposed mood disturbance (schizoaffective type), while the remaining seven were a mixture of paranoid, undifferentiated, and catatonic types. All morphometric measurements were conducted under strictly blind conditions; stepwise multiple regression and analyses of covariance were used to evaluate the effects of various confounding variables. There were no differences in the cross-sectional size of the hippocampus or degree of neuronal disarray between the two groups. Similarly, the number of pyramidal neurons was also the same in sectors Cornu Ammonis (CA) 2, CA 3, and CA 4 for the controls and schizophrenic subjects. In CA 1, the schizophrenic subjects without mood disturbances showed a significant reduction (36%) of pyramidal neuron numbers when compared with those of both controls and patients with mood disturbance. Pyramidal neurons were smaller in all sectors of the schizophrenic specimens, CA 1 (p less than or equal to 0.01), CA 2 (p less than or equal to 0.01), CA 3 (p less than or equal to 0.01), and CA 4 (p less than or equal to 0.005), but there were no differences with respect to the presence of mood disturbances. Corrections for the effects of age, postmortem interval, fixation interval, hypoxia, and neuroleptic exposure did not alter the pattern in the data. The significance of a smaller size of hippocampal pyramidal neurons in this group of schizophrenic specimens is unclear, but it is consistent with the suggestions of other laboratories that there may be altered function of this brain region in chronically psychotic individuals.

Entities:  

Mesh:

Year:  1991        PMID: 1805353     DOI: 10.1093/schbul/17.4.597

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  44 in total

Review 1.  Some neurobiological aspects of psychotherapy. A review.

Authors:  D Y Liggan; J Kay
Journal:  J Psychother Pract Res       Date:  1999

2.  Hippocampal pyramidal cell disarray correlates negatively to cell number: implications for the pathogenesis of schizophrenia.

Authors:  S A Jönsson; A Luts; N Guldberg-Kjaer; A Brun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 3.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

4.  Ketamine disrupts θ modulation of γ in a computer model of hippocampus.

Authors:  Samuel A Neymotin; Maciej T Lazarewicz; Mohamed Sherif; Diego Contreras; Leif H Finkel; William W Lytton
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

5.  Associations between adolescent cannabis use and brain structure in psychosis.

Authors:  Hila Abush; Subroto Ghose; Erin A Van Enkevort; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Matcheri S Keshavan; Carol A Tamminga; Elena I Ivleva
Journal:  Psychiatry Res Neuroimaging       Date:  2018-03-28       Impact factor: 2.376

6.  Hippocampal Network Modularity Is Associated With Relational Memory Dysfunction in Schizophrenia.

Authors:  Suzanne N Avery; Baxter P Rogers; Stephan Heckers
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-02-22

7.  Hippocampal morphometry in schizophrenia by high dimensional brain mapping.

Authors:  J G Csernansky; S Joshi; L Wang; J W Haller; M Gado; J P Miller; U Grenander; M I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 8.  Synapsin III: role in neuronal plasticity and disease.

Authors:  Barbara Porton; William C Wetsel; Hung-Teh Kao
Journal:  Semin Cell Dev Biol       Date:  2011-07-30       Impact factor: 7.727

9.  Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia.

Authors:  Julien Matricon; Alfredo Bellon; Helge Frieling; Oussama Kebir; Gwenaëlle Le Pen; Frédéric Beuvon; Catherine Daumas-Duport; Thérèse M Jay; Marie-Odile Krebs
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

Review 10.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.